Tenofovir DF in antiretroviral-experienced patients: results from a 48-week, randomized, double-blind study

To evaluate the safety and efficacy of once daily doses of tenofovir DF (TDF) administered in combination with other antiretroviral therapy (ART) in treatment-experienced HIV-1-infected patients with incomplete virological suppression. One-hundred and eighty-nine subjects with plasma HIV-1 RNA level...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	AIDS (London) 2002-06, Vol.16 (9), p.1257-1263
Hauptverfasser:	SCHOOLEY, Robert T, RUANE, Peter, MYERS, Robert A, BEALL, Gildon, LAMPIRIS, Harry, BERGER, Daniel, CHEN, Shan-Shan, MILLER, Michael D, ISAACSON, Erica, CHENG, Andrew K
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenine - adverse effects Adenine - analogs & derivatives Adenine - pharmacology Adenine - therapeutic use Adult Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral agents Biological and medical sciences CD4 Lymphocyte Count Double-Blind Method Drug Resistance, Viral Female HIV Infections - drug therapy HIV Infections - immunology HIV Infections - virology HIV-1 - drug effects HIV-1 - genetics HIV-1 - immunology HIV-1 - physiology Humans Male Medical sciences Organophosphonates Organophosphorus Compounds - adverse effects Organophosphorus Compounds - pharmacology Organophosphorus Compounds - therapeutic use Pharmacology. Drug treatments RNA, Viral - analysis Tenofovir Time Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!